Tootfinder

#Retatrutide,
An experimental GLP-1 drug pushes the limits of weight loss.
There are risks.
Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity to shed, on average, 28 percent of their body weight
— a substantial step up in potency from the existing crop of GLP-1 medicines.

But that breakthrough also is …

An experimental GLP-1 pushes the limits of weight loss. There are risks.
Eli Lilly is developing the the most powerful GLP-1 drug yet. But how much weight loss is too much?